(Q36426544)

14 August 2017

Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors (English)

1 reference

14 August 2017

1 reference

5

Bette Caan

1 reference

14 August 2017

4

Charles P Quesenberry

1 reference

14 August 2017

Marilyn L Kwan

1

1 reference

14 August 2017

Laurel A Habel

series ordinal

2

1 reference

14 August 2017

E Dawn Flick

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

3 August 2007

1 reference

Breast Cancer Research and Treatment

14 August 2017

1 reference

14 August 2017

109

1 reference

14 August 2017

3

1 reference

14 August 2017

573-579

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-007-9683-8

14 August 2017

0 references

cites work

Breast cancer growth prevention by statins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Statin use and breast cancer: prospective results from the Women's Health Initiative.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Statins and cancer prevention

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Therapy insight: Potential of statins for cancer chemoprevention and therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Statins and cancer development.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Cancer risk among statin users: a population-based cohort study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Statin use and cancer risk in the General Practice Research Database

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Statins can inhibit proliferation of human breast cancer cells in vitro

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Serum lipids, lipid-lowering drugs, and the risk of breast cancer

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Life After Cancer Epidemiology (LACE) Study: a cohort of early stage breast cancer survivors (United States).

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Statin use and the risk of breast and prostate cancer

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Statins and the Risk of Colorectal Cancer

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507509

Statin use and the risk of breast cancer

4 December 2018

1 reference

12 December 2020

The Risk of Cancer in Users of Statins

1 reference

12 December 2020

Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis

1 reference

12 December 2020

A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes

1 reference

12 December 2020

10.1007/S10549-007-9683-8

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

17674197

1 reference